Cargando…
pT1 Colorectal Cancer Detected in a Colorectal Cancer Mass Screening Program: Treatment and Factors Associated with Residual and Extraluminal Disease
SIMPLE SUMMARY: Our study has evaluated the burden of pT1 CRC (confined to submucosa) detected during the first round of a CRC screening program, the surgery related complications and the factors related to four relevant outcomes: initial endoscopic resection, surgery rescue and residual disease aft...
Autores principales: | Cubiella, Joaquín, González, Antía, Almazán, Raquel, Rodríguez-Camacho, Elena, Fontenla Rodiles, Juana, Domínguez Ferreiro, Carmen, Tejido Sandoval, Coral, Sánchez Gómez, Cristina, de Vicente Bielza, Natalia, Lorenzo, Isabel Peña-Rey, Zubizarreta, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565413/ https://www.ncbi.nlm.nih.gov/pubmed/32899974 http://dx.doi.org/10.3390/cancers12092530 |
Ejemplares similares
-
Overtreatment in nonmalignant lesions detected in a colorectal cancer screening program: a retrospective cohort study
por: Cubiella, Joaquín, et al.
Publicado: (2021) -
Impact of a colorectal cancer screening program implantation on delays and prognosis of non-screening detected colorectal cancer
por: Cubiella, Joaquin, et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on the Diagnosis of Colorectal Cancer within a Population-Based Organized Screening Program
por: Cubiella, Joaquín, et al.
Publicado: (2023) -
Polyprev: Randomized, Multicenter, Controlled Trial Comparing Fecal Immunochemical Test with Endoscopic Surveillance after Advanced Adenoma Resection in Colorectal Cancer Screening Programs: A Study Protocol
por: Regueiro, Cristina, et al.
Publicado: (2021) -
Faecal Immunochemical Test Impact on Prognosis of Colorectal Cancer Detected in Symptomatic Patients
por: Fernández de Castro, Jesús Daniel, et al.
Publicado: (2022)